Global Veterinary POC Diagnostic Market: By Product (Consumable, Instruments), By Technology (Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecular Diagnostics), By Application (Clinical pathology, Bacteriology, Virology, Parasitology, Orthopedics & traumatology, Gynecology, Oncology, Cardiology, Neurology), By Animal Type (Companion Animals, Livestock Animals) By End User (Veterinary Hospitals and Clinics, Home Care Settings) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2027

Market Forecast

Global Veterinary POC Diagnostic Market is expected to hold a value of USD 2,894 Million by 2027 and is expected to register a growth of 8.9% from 2020 to 2027.

Market Synopsis

Medical discoveries have made tremendous changes in the veterinary healthcare system like Point-of-Care (PoC), it enables rapid results in non-laboratory settings. There is traction in the veterinary point-of-care diagnostics market due to the adoption of advanced and innovative diagnostic testing methods. Increased prevalence of various pandemic diseases such as swine flu, rabies. Less period in testing and results, precise results, change in diagnostic trend, and adoption of state-of-art technologies are anticipated to foster the veterinary Point-of-Care (PoC) diagnostic market.

Market influencers

• growing companion animal population


• rising demand for pet insurance & growing animal health expenditure

Drivers

• growing prevalence of animal zoonotic diseases
  
  
  
  • There are at least 30 important diseases in humans that are transmitted through animals. Most human infections come from companion animals such as dogs and cats and livestock such as pigs, chicken, cattle, goats, and camels. Some of the major zoonotic diseases transmitted through animals to humans are zoonotic gastrointestinal disease, leptospirosis, cysticercosis, zoonotic tuberculosis, and rabies.
  
  
  
  

• Increasing number of veterinary practitioners

• Increase in income levels in developed economies

Restraints

• Increasing pet care costs.


• High cost of veterinary imaging instruments

Segmentation

By Product

Veterinary diagnostic products are as complex as they are difficult to manufacture. Many of the poultry and livestock diagnostic products are biologic products that demand materials from living organisms. Market development for companion animal diagnostic has depended heavily upon the purchasing and usage of in-clinic analyzers or diagnostic instruments used at veterinary practices. 

• Consumables: The appropriate consumables are essential for veterinary medicine. This not only refers to products for lab work, such as fecal sample containers and urine cups but also to items used for storing medications and instruments. Consumables accounted for the largest market share in 2019. The large share of the consumables segment can be attributed to the increasing demand for the rapid detection of diseases, the growing prevalence of animal zoonotic diseases, and growth in the companion animal population worldwide
  
  
  
  • Kits & Reagents: Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.
  
  
  • Imaging System Reagents: These instruments aid in the detection of diseases, fractures, and hemorrhages in animals.
  
  
  
  

• Instruments:
  
  
  
  • Imaging system: some of the imaging systems that are being used to diagnose the disease in animals. 
    
    
    
    • Radiography systems: Vet practitioners seek digital radiography systems for whole-body imaging. Increasing awareness about dental care increases the demand for a customized digital scanner for taking high-resolution dental images, which is anticipated to fuel the growth.
    
    
    • Digital equipment: Digital equipment has many advantages over traditional radiography X-ray systems as they help in reducing labor cost, time, and increasing profit margins of market players. These associated benefits are attributing to their higher demand.
    
    
    • Veterinary picture archiving and communication System (PACS): Increasing demand for systems with image sharing and information storage capabilities is contributing toward the segment share. To meet the imaging needs of veterinarians, companies are focusing on the development of advanced enterprise image viewing solutions.
    
    
    • Analyzers: Veterinary Clinic Chemistry Analyzer is used for blood chemistry tests that ensure precise and reliable results. With a compact system design, the VB1 features analyzer and DRI-CHEM from FUJIFILM is a dry chemistry analyzer which can perform multiple test parameters of Clinical Chemistry.
    
    
    
    
  
  
  
  

By Technology

• Clinical Biochemistry: Clinical biochemistry refers to the analysis of the blood plasma (or serum) for a wide variety of substances—substrates, enzymes, hormones, etc.—and their use in diagnosis and monitoring of disease. Analysis of other body fluids (e.g., urine, ascitic fluids, CSF) is also included. In 2019, the clinical biochemistry segment accounted for the largest share of the market. The higher preference for various advanced clinical diagnostic products by veterinarians and pet owners is contributing to the large share of this segment.

• Immunodiagnostics: Immunoblot analysis of serum and cerebrospinal fluid (CSF) provides antemortem information about exposure to  neurona. The test utilizes cultured merozoites to detect antibodies directed against proteins that are unique to S. neurona. Enzyme-linked immunosorbent assay (ELISA) segment accounted for a significant market size of USD 428.3 million in 2018 and is anticipated to dominate the immunodiagnostics segment over the forecast period. Various advantages associated with ELISA such as high sensitivity and reproducibility, quick results, easy of handling, and convenient automation will boost segment growth. Also, a wide array of applications of ELISA in the detection and diagnosis of various infectious diseases including canine scabies and porcine circovirus will be conducive to segmental growth.

• Hematology: Hematology segment accounted for market share. The technique is used to assess common hematological disturbances in veterinary practice. The test is capable of detecting bleeding disorder and other hidden abnormalities that will drive industry growth. Moreover, various advancements for the development of novel hematology analyzer with superior performance, elegant design, easy to use, true database management capability, and minimal maintenance will spur segment growth.

• Urinalysis: Urinalysis is a routine test that reports the physical and chemical properties of urine. It is used mainly to assess the health of the kidneys and urinary system, but it can also reveal problems in other organ systems, and is important for diagnosing metabolic disease such as diabetes mellitus. It is a valuable test in both healthy and sick animals and should be included in any comprehensive evaluation of a pet's health.

• Molecular Diagnostics: The molecular diagnostic is defined as a technique for use in the laboratory to identify a disease or its predisposition stage by analyzing the DNA or RNA or other proteins in humans and animals. Some of these techniques include amplification of nucleic acid like the polymerase chain reaction (PCR), peptide nucleic acids (PNA), fluorescent in situ hybridization (FISH), biochips, nanotechnology, proteomic technologies and electrochemical detection of DNA.

By Application

• Clinical pathology: The clinical pathology segment accounted for the largest market share in 2019. The growth in this segment can be attributed to the increasing adoption of chemistry analyzers for the primary diagnosis of diseases in clinics.

• Bacteriology: animals have bacteria living on and in them that cause diseases such as anthrax, black quarter, and tuberculosis. Apart from that, there are tests for mycoplasma, mycobacterium, leptospirosis, staphylococcal infection, actinomycosis, and reproductive testing for pet infertility.

• Virology: Virology is the study of viruses and virus-like agents, including (but not limited to) their taxonomy, disease-producing properties, cultivation, and genetics. It is often considered a part of microbiology or pathology. Some viruses that infect animals, swine flu, rabies, etc. rabies kills around 30,000 dogs every year mostly in Asia and Africa and it kills around 55,000 people each year globally.

• Parasitology: Veterinary parasitology is the study of animal parasites, especially relationships between parasites and animal hosts. Parasites of domestic animals, (livestock and pet animals), as well as wildlife animals, are considered such as roundworms, hookworms, whipworms, tapeworms, etc.

• Orthopedics & traumatology: Veterinary orthopedic surgeons specialize in surgeries to correct diseases and injuries of the bones, joints, ligaments, tendons, and other skeletal structures. Procedures that veterinary orthopedic surgeons perform include hip replacement, arthroscopic knee surgery, and repair of bone fractures with plates or nails and emergency neurologic surgery. Before they operate, veterinary orthopedists examine animals and use radiographs, magnetic resonance imaging, or ultrasound images for diagnosis.

• Gynecology: gynecology is the treatment related to female animals and their prevention from diseases. Nowadays, countries are mainly focusing on the development of methods and new technologies to detect the problems with female animals such as metabolic disorder in cow ketosis, milk fever, fat cow syndrome, and hypomagnesemia.

• Oncology: Cancer is a major cause of death in pet animals. In one study, 45% of the dogs that reached 10 years of age or older died of cancer.

• Cardiology: Cardiology is a study of diseases related to the structure, function, and disorders of the heart and circulatory system of an animal.

• Neurology: Veterinary neurology pertains to conditions affecting the brain, spinal cord, muscles, and nerves of animals. some diseases included in this are Seizures, Brain tumors, Epilepsy in dogs and cats, Herniated discs, Dog vestibular syndrome, Spinal tumors, Inflammatory diseases of the brain and spinal cord

By Animal Types

• Companion animals: In 2019, the companion animals segment accounted for the largest share of the veterinary point-of-care diagnostics industry. The increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure are the factors driving the growth of this segment.
  
  
  
  • Dogs: Dogs segment held the largest market in 2019 globally and is expected to dominate the market across the forecast timeframe. Availability of economical and quick DNA testing for hereditary diseases in companion animals and partnership with scientists to develop, validate, and deliver numerous testing options for breeders and pet owners are a few of the factors propelling business growth. Moreover, increasing adoption of dogs as companion animal coupled with growing pet expenditure will drive segment growth
  
  
  • Cats: Cats are susceptible to human tuberculosis caused by Mycobacterium tuberculosis, methicillin-resistant Staphylococcus aureus, and influenza A. Routine testing of companion animals during clinical visits is critical to control and prevent the spread of such diseases.
  
  
  • Horses: With recent outbreaks of EHV in 2015, most horse owners are somewhat aware of the dangers of this highly contagious virus. EHV is characterized by respiratory infections, paralysis, abortions, inflammation of the spinal cord, and occasionally death in young horses. This can be detected by the POC diagnosis.
  
  
  
  

• Livestock animals
  
  
  
  • Cattle: Anhrax, a highly infectious and fatal disease of cattle, is caused by a relatively large spore-forming rectangular shaped bacterium called Bacillus anthracis. Anthrax causes acute mortality in ruminants.
  
  
  • Swine: swine diseases not only affect the animal but also affect the human being such as swine flu.
  
  
  • Poultry: Poultry animals’ segment is forecasted to expand at 8.8% CAGR during the analysis period. High growth is attributed to the growing requirement for the diagnosis of various poultry diseases coupled with advances in veterinary diagnostics. Furthermore, detection of infectious diseases in poultry animals by various advanced testing methods that provide faster results, and customized protocols with the expert team for technical support and veterinary consulting are advantages that will propel segment growth.
  
  
  
  

By End-User

• Veterinary Hospitals and Clinics: The veterinary clinics segment accounted for the largest share of the veterinary point-of-care diagnostics market. The large share of this segment is attributed to the growing number of patients visiting vet clinics and the increasing number of private clinical practices. The hospitals and clinics dealing in veterinary health provide a huge range of veterinary diagnostic services such as 4D diagnostic imaging systems and software to the pet owners, ensuring the most effective therapeutics, including advanced diagnostic imaging, novel therapies, nuclear and regenerative medicines, laser diagnosis, and specialized surgeries. The trained specialists with the aid of advanced veterinary diagnostics provide early solutions for different diseases, neurology treatment, and appropriate medicines for pets.

• Home Care Settings: home care is when the owner looks after their animal and the physician makes the visits whenever necessary.

By Region

• Americas: North American market accounted for revenue of USD 1.7 billion in 2019. Growing pet animals’ adoption for companionship along with high animal healthcare expenditure will drive the North America veterinary POC diagnostic market. Advancements in veterinary diagnostics coupled with several laboratories adopting advanced molecular diagnostic techniques in the region will further propel market growth. Growing demand for animal-derived food due to rising awareness about its high nutritional content along with large scale animal farming in the US will drive industry growth.

• Europe: European market will grow at 7.8% during the forecast timeframe. Increasing demand for animal products coupled with a growing focus on biologicals that aids in developing various vaccines are factors driving animal diagnostics industry growth in Europe. High intake of animal food creates pressure on animal farms, thereby stimulating demand for animal diagnostics to control the prevalence of zoonotic and animal foodborne diseases. Moreover, government and private companies are taking joint efforts for the development and introduction of new diagnostic products, thus fostering business growth in the region.

• Asia-Pacific: Asia-Pacific is projected to register the fastest CAGR during the forecasted period, attributed to the rapid expansion of manufacturing facilities in the emerging economies such as China and India. Rising R&D investment by the key market players for the development of innovative value-added products is anticipated to drive the growth of companion animal diagnostics in the region over the forecast period.

• Middle East & Africa: The Middle-East & Africa veterinary POC diagnostic Market has seen an exemplar shift in the past few years with the emergence of new and technologically advanced products, which had an optimistic impact on the overall growth of the market

Key Players

• Thermo Fisher Scientific, Inc. (US)


• Idexx Laboratories, Inc. (US)


• Zoetis, Inc. (US)


• Virbac (France)


• Heska Corporation (US)


• Eurolyser Diagnostica GmbH (Austria)


• Woodley Equipment Company Ltd. (UK)


• Randox Laboratories, Ltd. (UK)


• Anipoc, Ltd. (UK)


• Carestream Health, Inc. (US)


• Neurologica Corporation (US)


• Fujifilm Sonosite, Inc. (Japan)


• Diagnostic Imaging Systems, Inc. (US)


• Esaote spa (Italy)


• Mindray Medical International Limited (A Part of Excelsior Union Limited) (China)


• GE Healthcare (US)


• Minxray, Inc. (US)


• QR s.r.l. (Italy)


• Sedecal (Spain)


• Examion GmbH (Germany)

Report Scope:

Report Attribute/Metric	Details
Market Size	2027: USD 2,894 Million
CAGR	8.9% (2020-2027)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product, Technology, Application, Animal Type and End User
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Thermo Fisher Scientific, Inc. (US), Idexx Laboratories, Inc. (US), Zoetis, Inc. (US), Virbac (France), Heska Corporation (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company Ltd. (UK), Randox Laboratories, Ltd. (UK), AniPoC, Ltd. (UK), Carestream Health, Inc. (US), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), GE Healthcare (US), Minxray, Inc. (US), QR s.r.l. (Italy), Sedecal (Spain), Examion GmbH (Germany).
Key Market Opportunities	growing companion animal population. rising demand for pet insurance & growing animal health expenditure.
Key Market Drivers	growing prevalence of animal zoonotic diseases. Increasing number of veterinary practitioners. Increase in income levels in developed economies.\r\n

Frequently Asked Questions (FAQ) :

---